CD28 and neoplasm: Hence, the authors developed another model by altering CD28 to determine the correlation between these two ligands by crossimplanting Foxp3creERT2 x Cd28f/f mice, which then were treated with TAM to delete CD28 in tumor-infiltrating Treg cells.